Meibomian gland dysfunction (MGD) is a common eye condition that is the root cause of evaporative dry eye. Meibum stagnation causes an unstable tear film, resulting in a shorter tear film breakup time and superficial punctate keratopathy (SPK) in the lower cornea, as well as punctate staining of the lower bulbar conjunctiva. The primary cause of meibomian gland dysfunction is believed to be an obstructive disorder caused by increased keratinization of the terminal ducts, the presence of squamous debris, and meibum thickening.
The market's developing companies are primarily focused on addressing unmet medical needs to detect the major underlying causes of dry eye disease in order to provide the best solution to the meibomian gland dysfunction treatment market.
The rising prevalence of dry eye disease increased awareness among ophthalmologists, and technological advancements in imaging analysis are expected to drive market growth during the forecast period. On the other hand, the availability of other substitute tests to diagnose dry eye syndrome is expected to restrain the global market growth during the forecast period.
Read more @ https://bit.ly/3dUeXQo
